DE:4OR / VivoSim Labs, Inc. - Net Long/Short Value

VivoSim Labs, Inc.
DE ˙ DB ˙ US68620A2033
DE:4OR / VivoSim Labs, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Morgan Stanley
Royal Bank Of Canada
SBI Securities Co., Ltd.
Citigroup Inc
Vanguard Fiduciary Trust Co
BlackRock, Inc.
Harbour Investments, Inc.
Wells Fargo & Company/mn
Golden State Wealth Management, LLC
Goldman Sachs Group Inc
Allworth Financial LP
Tower Research Capital LLC (TRC)
Albion Financial Group /ut
Hilton Head Capital Partners, LLC
Rockefeller Capital Management L.P.
Federation des caisses Desjardins du Quebec
Vanguard Capital Management Llc
Activest Wealth Management
Vanguard Group Inc
UBS Group AG
Geode Capital Management, Llc
Larson Financial Group LLC
Advisor Group Holdings, Inc.
Caitong International Asset Management Co., Ltd
First Command Advisory Services, Inc.
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:VIVS 1,35 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista